Picture [iito] Made Without Love 650x80px
Document › Details

MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY.

Organisations Organisation MeiraGTx Holdings Plc (NASDAQ: MGTX)
  Group MeiraGTx (Group)
  Organisation 2 Janssen (Group)
  Group Johnson & Johnson (JnJ) (Group)
Products Product gene therapy
  Product 2 AAV-RPE65 gene therapy (MeiraGTx)
Index term Index term JnJ–MeiraGTx: gene therapy, 201901– collab r+d + license ww excl $100m upfront + milestones + funding + 20% royalties for inherited retinal diseases
Persons Person Forbes, Alexandria (MeiraGTx 201810 CEO)
  Person 2 Broder, Elizabeth (MeiraGTx 201901 Investor Relations)

Record changed: 2019-04-03


Picture [iito] Made Without Love 650x80px

More documents for MeiraGTx (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top